ACCESS Newswire

Neeyamo Inc.

Share
Experience the Future With Neeyamo's Autonomous Global Payroll Solution

Neeyamo Payroll ™ 3.0 offers organizations a hyper-automated, holistically-global, and fully-integrated payroll solution that caters to their multi-country payroll needs.

DENVER, CO / ACCESSWIRE / May 16, 2023 / Neeyamo, a market leader in global payroll and global work solutions, announced the launch of Neeyamo Payroll ™ 3.0 at the prestigious Payroll Congress on May 16, 2023.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Neeyamo Payroll ™ 3.0
Neeyamo Payroll ™ 3.0

Payroll 3.0 is a revolutionary upgrade to its Neeyamo Payroll product that can process global payroll in less than five clicks. It is an unrivaled global solution entirely in-house, unburdened by any ICP or external software.

Payroll 3.0 heralds a new era of autonomous global payroll and offers organizations a panoramic view of their payroll operations. Real-time insights and intuitive visualizations provide the ability to monitor compliance and make data-driven decisions. Smart AI and ML-driven input and output validation eradicates errors and discrepancies, automates tax compliance, and simplifies complex payroll calculations.

At the heart of its ability to process payroll faster is the single global payroll platform bolstered by native gross-to-net capabilities in 100+ countries. This comprehensive global coverage ensures seamless payroll operations across diverse geographical locations, enabling organizations to navigate complex payroll requirements effortlessly.

With a powerful global dashboard to provide actionable intelligence, a smart payroll console that oversees input and output validation, and infinite pay drafts that allows unparalleled flexibility and accuracy, organizations can confidently navigate the payroll landscape.

Neeyamo's dedication to simplifying the global payroll chaos while ensuring compliance, accuracy, and efficiency is at the heart of Payroll 3.0, which seamlessly blends precision and innovation.

Speaking about the launch, Ashok Bildikar, Chairman and Managing Director at Neeyamo, said, "With its powerful global dashboard, smart payroll console, faster processing times, and infinite pay drafts, Payroll 3.0 represents our commitment to revolutionizing payroll management and delivering exceptional value to our clients worldwide. Join us in embracing the power of autonomous global payroll, and don't miss out on this opportunity to be at the forefront of the payroll revolution."

About Neeyamo

Neeyamo is a leading technology-enabled global payroll and EOR solutions provider for multinational and micro-multinational corporations worldwide. With an extensive team of professionals serving clients across 160+ countries, Neeyamo leverages its unique service-based model and functionality-rich, next-generation HR & payroll products portfolio to help organizations enable agile and scalable business. Ignite your payroll revolution and get to know more at www.neeyamo.com or send us an email at irene.jones@neeyamo.com.

Contact Information:

Irene Jones
Global Payroll Evangelist & Thought Leader
irene.jones@neeyamo.com

SOURCE: Neeyamo

To view this piece of content from stats.newswire.com, please give your consent at the top of this page.

View source version on accesswire.com:
https://www.accesswire.com/755220/Experience-the-Future-With-Neeyamos-Autonomous-Global-Payroll-Solution

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper

Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release

VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc

GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release

MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o

GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release

Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring

Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release

DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye